Hematology topics for General Physicians
How hematology is tested
Written for DHA, SMLE, DOH, QCHP, OMSB, MOH, NHRA and Kuwait MOH — the same GP licensing mix, not a hematology specialist paper.
Haematology on DHA, SMLE, DOH, QCHP, OMSB, MOH, NHRA and Kuwait MOH is MCV-based anaemia, sickle crises in the region, thrombocytopenia splits, DOAC/warfarin reversal and transfusion thresholds — not leukaemia karyotypes.
Start every anaemia stem with MCV, then iron studies vs B12/folate vs haemolysis labs. Sickle cell vaso-occlusive crisis, ACS and exchange indications are regionally high-yield.
HIT vs ITP vs DIC is a pattern question. VTE treatment and when to reverse anticoagulation appear more often than lymphoma staging.
How do I approach a low haemoglobin in these MCQs?
MCV first, then the matching panel. Do not transfuse a stable iron-deficient young woman because the number looks ugly; treat the cause and use thresholds from the stem’s haemodynamics.
What sickle complications are tested?
Acute chest, stroke, sequestration and priapism. Oxygen, fluids, analgesia and when to exchange — not hydroxyurea pharmacokinetics.
Warfarin reversal — what do they want?
Major bleed: four-factor PCC plus vitamin K, not FFP-first in a centre that has PCC. DOAC reversal is agent-specific when the named antidote is an option.
More Medicine subspecialties